TNF-Blockade und Krebsleiden
نویسندگان
چکیده
منابع مشابه
10 TNF Blockade: An Inflammatory Issue
Tumor necrosis factor (TNF), initially discovered as a result of its antitumor activity, has now been shown to mediate tumor initiation, promotion, and metastasis. In addition, dysregulation of TNF has been implicated in a wide variety of inflammatory diseases including rheumatoid arthritis, Crohn’s disease, multiple sclerosis, psoriasis, scleroderma, atopic dermatitis, systemic lupus erythemat...
متن کاملA monocyte‐TNF‐endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade
Elaboration of tumor necrosis factor (TNF) is a very early event in development of ischemia/reperfusion injury pathophysiology. Therefore, TNF may be a prominent mediator of endothelial cell and vascular wall dysfunction in sickle cell anemia, a hypothesis we addressed using NY1DD, S+SAntilles , and SS-BERK sickle transgenic mice. Transfusion experiments revealed participation of abnormally act...
متن کاملHip arthritis in the TNF-Blockade era: an unresolved issue?
Hip imaging in 8 PHD children showed cartilage destruction, erosions and sclerosis (7) osteonecrosis of the femoral head (6), AVN (1), extensive osteophyte formation (1). Discussion In this cohort of 15 patients treated with TNF blockade, 8 patients had progressive hip disease despite better control of articular and systemic inflammation in the majority of them. Our findings suggest that the ri...
متن کاملThe Changing Face of Spondyloarthropathies Under TNF α Blockade
OBJECTIVES Tumor necrosis factor alpha (TNF-α ) therapy has been implicated in the development of autoimmune diseases. Our aim was to describe three patients with spondyloarthropathies who responded to infliximab, a chimeric monoclonal antibody specific for TNF-α but developed new symptoms of spondyloarthropathies. In parallel, a review of the literature on psoriasis induced by TNF-α blockers w...
متن کاملBlockade oder Unterstützung? Zum Verhältnis von Standards und IPR
Es werden Konflikte und Lösungstendenzen im Verhältnis von offenen Standards und Intellectual Property Rights betrachtet. Dabei werden verschiedene Patent Policies vorgestellt. Eine zusammenfassende Schlussbetrachtung formuliert Möglichkeiten des Ausgleichs.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
سال: 2012
ISSN: 1424-4020,1424-3784
DOI: 10.4414/smf.2012.07766